SCWorx Resumes Nasdaq Trading With 122% Gross Profit Surge and New Hospital Wins
WORX has more than doubled off its 52-week low of $2.3 on elevated volume (28× avg).
Summary
SCWorx resumed trading on Nasdaq today after the Hearings Panel reversed its delisting decision, clearing a major overhang. The company paired the milestone with concrete operating improvements: H1 gross profit jumped 122% to $705K on modest revenue growth, net loss shrank to $295K from $2.4M, and operating cash burn fell to $258K from $1.1M. New customer wins include a teaching hospital using SCWorx for a Workday implementation and a two-year deal with a large Massachusetts health network. The stock remains under a one-year Panel Monitor, so any compliance slip would trigger immediate delisting without a cure period.
At the time of this announcement, WORX was trading at $6.11 on OTC in the Technology sector, with a market capitalization of approximately $3.4M. The 52-week trading range was $2.30 to $220.32. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.